Acetylated Natural Nucleotides in Treating Hand-foot Syndrome
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The clinical trial is planned to investigate the efficacy and safety of acetylated natural
nucleotides in treating anti-cancer medications induced hand-foot syndrome (HFS).